retinal vein occlusion
Conditions
Interventions
use of topical bromfenac
use of artificial lacrimal fluid
Sponsors
Juntendo Urayasu Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1)The patients who received enough explanation about the purpose of this study, was obtained its consent 2)the patients who had macula edema due to retinal vein occlusion from the onset of less than 12 months
Exclusion criteria
Exclusion criteria: 1) The patient who has difficulty in periodical going to hospital. 2)The patients who have had vitrectomy surgery or anti-VEGF injection. 3)The patient who received intraocular operation within three months before first injection. 4)The patient that it was judged to be inappropriate as an object of this study. 5)The patients who had other disease which induce visual disorder.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| visual acuity at the time of 12 month from injection | — |
Secondary
| Measure | Time frame |
|---|---|
| central macula thickness at the time of 12 month from injection, injection number during 12 months | — |
Countries
Japan
Contacts
Public ContactYoshihito Sakanishi
Juntendo Urayasu Hospital Ophthalmology
Outcome results
None listed